EFL
Merged or Acquired

Cohort Year: 2025-2026

Tracks: Life Sciences

VISIT WEBSITE

Coiled Therapeutics

Coiled Therapeutics is developing next-generation cancer therapies targeting key driver pathways with a first-in-class, orally available small molecule TACC3 inhibitor.